U2Bio Co., Ltd. (KOSDAQ:221800)
5,140.00
-350.00 (-6.38%)
At close: Dec 5, 2025
86.91% (1Y)
| Market Cap | 70.57B |
| Revenue (ttm) | 25.59B |
| Net Income (ttm) | -2.99B |
| Shares Out | 13.54M |
| EPS (ttm) | -265.81 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 529,287 |
| Average Volume | 3,881,965 |
| Open | 5,510.00 |
| Previous Close | 5,490.00 |
| Day's Range | 5,110.00 - 5,570.00 |
| 52-Week Range | 2,370.00 - 7,900.00 |
| Beta | -0.20 |
| RSI | 49.72 |
| Earnings Date | n/a |